Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study
出版年份 2011 全文链接
标题
Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study
作者
关键词
-
出版物
PLOS MEDICINE
Volume 8, Issue 7, Pages e1001067
出版商
Public Library of Science (PLoS)
发表日期
2011-07-27
DOI
10.1371/journal.pmed.1001067
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High Incidence of Hospital Admissions With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Among South African Health Care Workers
- (2013) Max R. O'Donnell et al. ANNALS OF INTERNAL MEDICINE
- Evaluation of the Cepheid Xpert MTB/RIF Assay for Direct Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens
- (2011) E. M. Marlowe et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparison of the Xpert MTB/RIF Test with an IS6110-TaqMan Real-Time PCR Assay for Direct Detection of Mycobacterium tuberculosis in Respiratory and Nonrespiratory Specimens
- (2011) S. Armand et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System
- (2011) D. Hillemann et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
- (2011) Catharina C Boehme et al. LANCET
- Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies
- (2011) Haileyesus Getahun et al. PLOS MEDICINE
- Tuberculosis Screening in Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Stretching Diagnostics to the Limits
- (2010) S. D. Lawn et al. CLINICAL INFECTIOUS DISEASES
- Intensive Tuberculosis Screening for HIV‐Infected Patients Starting Antiretroviral Therapy in Durban, South Africa
- (2010) Ingrid V. Bassett et al. CLINICAL INFECTIOUS DISEASES
- Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay
- (2010) R. Blakemore et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Rapid Detection of Mycobacterium tuberculosis Complex and Rifampin Resistance in Smear-Negative Clinical Samples by Use of an Integrated Real-Time PCR Method
- (2010) R. Moure et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
- (2010) Neel R Gandhi et al. LANCET
- Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis
- (2010) Katharina Kranzer et al. LANCET INFECTIOUS DISEASES
- Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
- (2010) Catharina C. Boehme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease
- (2009) Stephen D Lawn et al. AIDS
- Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa
- (2009) Stephen D Lawn et al. AIDS
- HIV Coinfection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality
- (2009) Neel R. Gandhi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Rapid Detection ofMycobacterium tuberculosisand Rifampin Resistance by Use of On-Demand, Near-Patient Technology
- (2009) Danica Helb et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings
- (2009) Michael JA Reid et al. LANCET INFECTIOUS DISEASES
- Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
- (2008) Stephen D Lawn et al. AIDS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started